|1.||Nakanuma, Yasuni: 5 articles (08/2011 - 11/2006)|
|2.||Chu, Peiguo G: 5 articles (01/2009 - 08/2002)|
|3.||Weiss, Lawrence M: 5 articles (01/2009 - 08/2002)|
|4.||Cheng, Liang: 5 articles (04/2008 - 08/2006)|
|5.||Lopez-Beltran, Antonio: 4 articles (04/2008 - 11/2006)|
|6.||Montironi, Rodolfo: 4 articles (04/2008 - 11/2006)|
|7.||Ordóñez, N G: 4 articles (12/2001 - 05/2000)|
|8.||Weitz, J: 4 articles (01/2001 - 01/2000)|
|9.||Kalthoff, Holger: 3 articles (05/2015 - 10/2005)|
|10.||Röder, Christian: 3 articles (05/2015 - 10/2005)|
10/01/2011 - "We have found that the endocytic oncoprotein Huntingtin-interacting protein 1 (HIP1) is expressed at high levels in ∼90% of MCC tumors and serves as a more reliable histological cytoplasmic stain than the gold standard, cytokeratin 20. "
01/01/2014 - "Among the 191 genes demonstrating significant differential expression between prognostic groups, keratin 20 and neurofilament protein have previously been identified in studies of MCC and were significantly upregulated in tumors from patients with a poor prognosis. "
04/01/2013 - "In this study cytokeratin-20 (CK20) was evaluated by real-time RT-PCR as a marker for circulating CRC cell detection and the influence of surgical tumor resection on the presence of circulating CRC cells was analyzed. "
09/01/2007 - "We conducted this study to determine the presence of disseminated tumor cells in the lymph nodes by quantitative real-time polymerase chain reaction (QRT-PCR) for cytokeratin 20 (CK20) in an attempt to provide supplementary information compared to histopathological findings. "
12/01/2004 - "Several studies have shown the utility of cytokeratin 20 to differentiate MCC from other small round blue cell tumors, particularly those with neuroendocrine differentiation. "
|2.||Urinary Bladder Neoplasms (Bladder Cancer)
12/01/2015 - "Cytokeratin 20 and survivin were used as confirmed markers of bladder cancer. "
02/01/2010 - "ImmunoCyt and cytokeratin 20 immunocytochemistry as adjunct markers for urine cytologic detection of bladder cancer: a prospective study."
01/01/2009 - "We decided to verify the ImmunoCyt/uCyt+ (UCyt+) test and cytology combination and cytokeratin 20 (CK20) and cytology combination in urine as possible diagnostic and monitoring tool for bladder cancer. "
12/01/2000 - "Cytokeratin 20 is a cytoskeletal protein expressed in colon and bladder cancer cells but only rarely in normal urothelium. "
12/01/2000 - "Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer."
01/01/2014 - "Significant difference in expression of Cytokeratin 20 and p53 was found between low and high grade urothelial carcinoma. "
01/01/2014 - "As grading these carcinomas are of utmost prognostic significance after depth of invasion, therefore we evaluated the role of immunohistochemical expression of p53 and cytokeratin 20 as an adjuctive tool in grading urothelial carcinoma. "
01/01/2013 - "Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens."
01/01/2013 - "Cytokeratin 20 was expressed in 28 (90.3%) of the 31 intestinal-type carcinomas, whereas it was always negative in the pancreaticobiliary histotype; CK7 was expressed in 32 (91.4%) of the 35 pancreaticobiliary-type carcinomas and in 18 (58.1%) of the 31 intestinal-type carcinomas. "
09/01/2012 - "To investigate the value of cytokeratin 20 (CK20) immunocytochemical (ICC) detection in the urine liquid-based cytological specimens in diagnosis of urothelial carcinoma (UC). "
02/01/2015 - "Cytokeratin 20 and 7 are expressed in esophageal adenocarcinoma. "
01/01/2014 - "Expression of cytokeratin 20 indicates invasive histological phenotype in poorly differentiated colorectal adenocarcinoma."
12/01/2008 - "Immunohistochemistry showed that the adenocarcinoma cells were diffusely positive for cytokeratin 20 (CK20) and caudal-type homeobox transcription factor-2 (CDX2) but negative for CK7, confirming the colonic phenotype. "
02/01/2006 - "Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival."
07/01/2004 - "Staining for cytokeratin 20 was positive in 84% of ITACs, including all cases negative for CDX-2, but negative in all other adenocarcinomas. "
|5.||Merkel Cell Carcinoma
08/01/2009 - "This is the first report describing now cytokeratin 20 was clearly beneficial for the differential diagnosis of feline Merkel cell carcinoma."
07/01/2012 - "Cytokeratin 20 and Merkel cell polyomavirus were detected in all cases of primary Merkel cell carcinoma irrespective of their site of origin. "
04/01/2009 - "The neoplastic cells show strong perinuclear staining for cytokeratin 20 (CK20) with a dot-like pattern, supporting our contention that this is an unusual variant of Merkel cell carcinoma. "
01/01/2009 - "The pathologic diagnosis of Merkel cell carcinoma (MCC) is mainly based on routine morphology and a characteristic cytokeratin 20 (CK20) immunohistochemical staining pattern. "
06/01/2007 - "Distinct paranuclear dot-like expression of cytokeratin 20 showed the lesion to be metastatic Merkel cell carcinoma. "
|1.||Keratin-7 (Cytokeratin 7)
|2.||Messenger RNA (mRNA)
|4.||thyroid nuclear factor 1 (thyroid transcription factor 1)
|2.||Lymph Node Excision (Lymph Node Dissection)
|3.||Drug Therapy (Chemotherapy)
|5.||Mohs Surgery (Mohs' Micrographic Surgery)